cbdMD (YCBD) Long-Term Deferred Tax (2016 - 2021)
cbdMD (YCBD) reported Long-Term Deferred Tax of $165000.0 for Q3 2021, down 97.21% on a YoY basis from $5.9 million in Q3 2020, and down 97.21% sequentially from $5.9 million in Q3 2020.
cbdMD (YCBD) Long-Term Deferred Tax (2016 - 2021) Analysis & Trends
cbdMD (YCBD) has 6 years of Long-Term Deferred Tax data on file, last reported at $165000.0 in Q3 2021.
- For the quarter ending Q3 2021, Long-Term Deferred Tax fell 97.21% year-over-year to $165000.0; the trailing twelve-month figure through Sep 2021 stood at $165000.0 (down 97.21% YoY), and the FY2021 full-year result was $165000.0, down 97.21% from the prior year.
- Long-Term Deferred Tax retreated to $165000.0 in Q3 2021, from $5.9 million in the prior quarter.
- In the past five years, Long-Term Deferred Tax ranged from a high of $6.8 million in Q3 2019 to a low of $19000.0 in Q1 2018.
- A 5-year average of $2.6 million and a median of $165000.0 in 2021 frame the typical range for Long-Term Deferred Tax.
- Across the five-year window, Long-Term Deferred Tax plunged 97.58% in 2017 and decreased 13.09% in 2020, its largest moves.
- Tracing YCBD's Long-Term Deferred Tax over 5 years: stood at $37000.0 in 2017, then slumped by 48.65% to $19000.0 in 2018, then jumped by 35714.21% to $6.8 million in 2019, then fell by 13.09% to $5.9 million in 2020, then tumbled by 97.21% to $165000.0 in 2021.
- Business Quant data shows YCBD's Long-Term Deferred Tax at $165000.0 in Q3 2021, $5.9 million in Q3 2020, and $6.8 million in Q3 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | cbdMD | 438,678.80 | -2.95 Mn | 3.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 165,000.00 |
| Sep 30, 2020 | 5.91 Mn |
| Sep 30, 2019 | 6.80 Mn |
| Mar 31, 2018 | 19,000.00 |
| Sep 30, 2017 | 37,000.00 |
| Sep 30, 2016 | 1.53 Mn |